These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

345 related articles for article (PubMed ID: 27214757)

  • 21. Split Liver Transplantation and Pediatric Waitlist Mortality in the United States: Potential for Improvement.
    Perito ER; Roll G; Dodge JL; Rhee S; Roberts JP
    Transplantation; 2019 Mar; 103(3):552-557. PubMed ID: 29684000
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impact of the acuity circle model for liver allocation on multivisceral transplant candidates.
    Ivanics T; Vianna R; Kubal CA; Iyer KR; Mazariegos GV; Matsumoto CS; Mangus R; Beduschi T; Abouljoud M; Fridell JA; Nagai S
    Am J Transplant; 2022 Feb; 22(2):464-473. PubMed ID: 34403552
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impact of the hepatopulmonary syndrome MELD exception policy on outcomes of patients after liver transplantation: an analysis of the UNOS database.
    Goldberg DS; Krok K; Batra S; Trotter JF; Kawut SM; Fallon MB
    Gastroenterology; 2014 May; 146(5):1256-65.e1. PubMed ID: 24412528
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A 10-Year united network for organ sharing review of mortality and risk factors in young children awaiting liver transplantation.
    Leung DH; Narang A; Minard CG; Hiremath G; Goss JA; Shepherd R
    Liver Transpl; 2016 Nov; 22(11):1584-1592. PubMed ID: 27541809
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Waitlist Outcomes for Patients Relisted Following Failed Donation After Cardiac Death Liver Transplant: Implications for Awarding Model for End-Stage Liver Disease Exception Scores.
    Croome KP; Lee DD; Nguyen JH; Keaveny AP; Taner CB
    Am J Transplant; 2017 Sep; 17(9):2420-2427. PubMed ID: 28556380
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Transplant Center Variability in Organ Offer Acceptance and Mortality Among US Patients on the Heart Transplant Waitlist.
    Choi AY; Mulvihill MS; Lee HJ; Zhao C; Kuchibhatla M; Schroder JN; Patel CB; Granger CB; Hartwig MG
    JAMA Cardiol; 2020 Jun; 5(6):660-668. PubMed ID: 32293647
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Model for End-Stage Liver Disease/Pediatric End-Stage Liver Disease exception policy and outcomes in pediatric patients with hepatopulmonary syndrome requiring liver transplantation.
    Raza MH; Kwon Y; Kobierski P; Misra AC; Lim A; Goldbeck C; Etesami K; Kohli R; Emamaullee J
    Liver Transpl; 2023 Feb; 29(2):134-144. PubMed ID: 35876731
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Exception Policy Change Increased the Simultaneous Kidney-Liver Transplant Probability of Polycystic Disease in the Centers With High Median MELD at Transplantation.
    Miyake K; Kim DY; Chau LC; Trudeau S; Kitajima T; Wickramaratne N; Shimada S; Nassar A; Yoshida A; Abouljoud MS; Nagai S
    Transplantation; 2024 Jul; 108(7):1632-1640. PubMed ID: 38548699
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Predictors of low risk for dropout from the liver transplant waiting list for hepatocellular carcinoma in long wait time regions: Implications for organ allocation.
    Mehta N; Dodge JL; Hirose R; Roberts JP; Yao FY
    Am J Transplant; 2019 Aug; 19(8):2210-2218. PubMed ID: 30861298
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inferior Outcomes on the Waiting List in Low-Volume Pediatric Heart Transplant Centers.
    Rana A; Fraser CD; Scully BB; Heinle JS; McKenzie ED; Dreyer WJ; Kueht M; Liu H; Brewer ED; Rosengart TK; O'Mahony CA; Goss JA
    Am J Transplant; 2017 Jun; 17(6):1515-1524. PubMed ID: 28251816
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Center variation in the use of nonstandardized model for end-stage liver disease exception points.
    Goldberg DS; Makar G; Bittermann T; French B
    Liver Transpl; 2013 Dec; 19(12):1330-42. PubMed ID: 24039090
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Waiting list outcome of Peld/Meld exceptions: A single-center experience in Argentina.
    Lauferman L; Dip M; Halac E; Cervio G; Aredes D; Capparelli M; Reijenstein H; Minetto J; Rojas L; Goñi J; Jacobo Dillon A; Martinitto R; Imventarza O
    Pediatr Transplant; 2018 Mar; 22(2):. PubMed ID: 29297966
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Outcomes After Declining a Steatotic Donor Liver for Liver Transplant Candidates in the United States.
    Jackson KR; Bowring MG; Holscher C; Haugen CE; Long JJ; Liyanage L; Massie AB; Ottmann S; Philosophe B; Cameron AM; Segev DL; Garonzik-Wang J
    Transplantation; 2020 Aug; 104(8):1612-1618. PubMed ID: 32732838
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impact of MELD 30-allocation policy on liver transplant outcomes in Italy.
    Ravaioli M; Lai Q; Sessa M; Ghinolfi D; Fallani G; Patrono D; Di Sandro S; Avolio A; Odaldi F; Bronzoni J; Tandoi F; De Carlis R; Pascale MM; Mennini G; Germinario G; Rossi M; Agnes S; De Carlis L; Cescon M; Romagnoli R; De Simone P
    J Hepatol; 2022 Mar; 76(3):619-627. PubMed ID: 34774638
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Improved survival in simultaneous lung-liver recipients and candidates in the modern era of lung allocation.
    Freischlag K; Schroder PM; Ezekian B; Cox ML; Mulvihill MS; Hartwig MG; Knechtle SJ
    J Surg Res; 2018 Nov; 231():395-402. PubMed ID: 30278959
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Analysis of Liver Offers to Pediatric Candidates on the Transplant Wait List.
    Hsu EK; Shaffer ML; Gao L; Sonnenday C; Volk ML; Bucuvalas J; Lai JC
    Gastroenterology; 2017 Oct; 153(4):988-995. PubMed ID: 28711630
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pediatric Liver Transplant Center Volume and the Likelihood of Transplantation.
    Rana A; Pallister Z; Halazun K; Cotton R; Guiteau J; Nalty CC; O'Mahony CA; Goss JA
    Pediatrics; 2015 Jul; 136(1):e99-e107. PubMed ID: 26077479
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dramatic secular changes in prognosis for kidney transplant candidates in the United States.
    Schold JD; Arrigain S; Flechner SM; Augustine JJ; Sedor JR; Wee A; Goldfarb DA; Poggio ED
    Am J Transplant; 2019 Feb; 19(2):414-424. PubMed ID: 30019832
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Do Social Determinants Define "Too Sick" to Transplant in Patients With End-stage Liver Disease?
    Bababekov YJ; Hung YC; Chang DC; Rickert CG; Adler JT; Bethea E; Pomfret EA; Pomposelli JJ; Yeh H
    Transplantation; 2020 Feb; 104(2):280-284. PubMed ID: 31335769
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Use of model for end-stage liver disease exceptions for donation after cardiac death graft recipients relisted for liver transplantation.
    Maduka RC; Abt PL; Goldberg DS
    Liver Transpl; 2015 Apr; 21(4):554-60. PubMed ID: 25597393
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.